MEDIROM Healthcare Technologies Reports April 2025 KPIs and Expands Health Tech Reach

An announcement from MEDIROM Healthcare Technologies ( (MRM) ) is now available.

On May 20, 2025, MEDIROM Healthcare Technologies Inc. announced its updated Key Performance Indicators (KPIs) for April 2025. Despite a slight reduction in the number of salons, the company increased its total customers served, reflecting improved operational efficiency. The sales per customer remained significantly above the industry average, and the customer repeat ratio was strong. Additionally, the company has expanded its health tech business, with the Lav® app reaching over 10,000 users and entering into contracts with 100 corporate insurance associations, indicating a growing market presence.

The most recent analyst rating on (MRM) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on MEDIROM Healthcare Technologies stock, see the MRM Stock Forecast page.

Spark’s Take on MRM Stock

According to Spark, TipRanks’ AI Analyst, MRM is a Neutral.

MEDIROM Healthcare Technologies presents a complex picture. The stock benefits from strong revenue growth and an attractive P/E ratio, suggesting undervaluation. However, significant risks are associated with its high leverage, cash flow challenges, and potential technical resistance. The neutral technical indicators provide some stability, but profitability and liquidity concerns weigh on the overall outlook.

To see Spark’s full report on MRM stock, click here.

More about MEDIROM Healthcare Technologies

MEDIROM Healthcare Technologies Inc. is a holistic healthcare company based in Japan, primarily focused on salon operations and health tech services. The company operates salons and offers a health guidance program using its Lav® app, which supports lifestyle improvements through remote guidance.

Average Trading Volume: 1,620,305

Technical Sentiment Signal: Sell

Current Market Cap: $6.24M

See more insights into MRM stock on TipRanks’ Stock Analysis page.